Linked Life Data

18166099

Source:http://linkedlifedata.com/resource/pubmed/id/18166099

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2008-1-1
pubmed:abstractText
Non-steroidal anti-inflammatory agents inhibit the production of cyclooxygenase (COX) products and can attenuate bone loss. In this double-masked, placebo-controlled, randomized clinical trial, the efficacy of celecoxib (COX-2 inhibitor) was evaluated in conjunction with scaling and root planing (SRP) in subjects with chronic periodontitis (CP).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
D
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0022-3492
pubmed:author
pubmed:issnType
Print
pubmed:volume
79
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
104-13
pubmed:meshHeading
pubmed-meshheading:18166099-Adolescent, pubmed-meshheading:18166099-Adult, pubmed-meshheading:18166099-Aged, pubmed-meshheading:18166099-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:18166099-Chronic Disease, pubmed-meshheading:18166099-Combined Modality Therapy, pubmed-meshheading:18166099-Cyclooxygenase Inhibitors, pubmed-meshheading:18166099-Dental Plaque Index, pubmed-meshheading:18166099-Dental Scaling, pubmed-meshheading:18166099-Double-Blind Method, pubmed-meshheading:18166099-Female, pubmed-meshheading:18166099-Follow-Up Studies, pubmed-meshheading:18166099-Gingival Hemorrhage, pubmed-meshheading:18166099-Humans, pubmed-meshheading:18166099-Male, pubmed-meshheading:18166099-Middle Aged, pubmed-meshheading:18166099-Periodontal Attachment Loss, pubmed-meshheading:18166099-Periodontal Pocket, pubmed-meshheading:18166099-Periodontitis, pubmed-meshheading:18166099-Placebos, pubmed-meshheading:18166099-Pyrazoles, pubmed-meshheading:18166099-Root Planing, pubmed-meshheading:18166099-Sulfonamides, pubmed-meshheading:18166099-Tooth Mobility, pubmed-meshheading:18166099-Treatment Outcome
pubmed:year
2008
pubmed:articleTitle
The effect of a selective cyclooxygenase-2 inhibitor (celecoxib) on chronic periodontitis.
pubmed:affiliation
Department of Oral Medicine, Tufts University School of Dental Medicine, Boston, MA 02111, USA. cyen01@tufts.edu
pubmed:publicationType
Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase IV